Dural metastases

被引:101
作者
Laigle-Donadey, F
Taillibert, S
Mokhtari, K
Hildebrand, J
Delattre, JY
机构
[1] Grp Hosp Pitie Salpetriere, Federat Neurol Mazarin, F-75651 Paris, France
[2] Grp Hosp Pitie Salpetriere, Serv Neuropathol, F-75634 Paris, France
关键词
dural; meningioma; metastasis; subdural hematoma; surgical removal;
D O I
10.1007/s11060-004-8098-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dural metastases are found at autopsy in 8-9% of patients with advanced systemic cancer. They arise either by direct extension from skull metastases or by hematogeneous spread. Dural metastases are often clinically asymptomatic but they may produce progressive neurological deficits and sometimes subdural hematomas. MRI may be misleading when the metastasis simulates a meningioma or when a subdural hematoma masks the underlying tumor. Whenever possible, surgical removal is the most appropriate treatment. The prognosis is poor because of the progressive systemic cancer but prolonged survival has been reported in operated patients, when the systemic cancer was controlled.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 67 条
  • [1] Ahn JY, 2002, J NEURO-ONCOL, V58, P193
  • [2] AMBIAVAGAR PC, 1978, CANCER, V42, P2015, DOI 10.1002/1097-0142(197810)42:4<2015::AID-CNCR2820420450>3.0.CO
  • [3] 2-Q
  • [4] Auer IA, 1998, CLIN NEUROPATHOL, V17, P190
  • [5] Diagnosing dural metastases:: the value of 1H magnetic resonance spectroscopy
    Bendszus, M
    Warmuth-Metz, M
    Burger, R
    Klein, R
    Tonn, JC
    Solymosi, L
    [J]. NEURORADIOLOGY, 2001, 43 (04) : 285 - 289
  • [6] Dural metastases in prostate cancer
    Bentley, AMH
    Keen, JC
    [J]. CLINICAL ONCOLOGY, 2003, 15 (03) : 165 - 166
  • [7] SUBDURAL-HEMATOMA DUE TO DURAL METASTASIS - CASE-REPORT AND REVIEW OF THE LITERATURE
    BERGMANN, M
    PUSKAS, Z
    KUCHELMEISTER, K
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 1992, 94 (03) : 235 - 240
  • [8] METASTATIC ADENOCARCINOMA OF THE PROSTATE AS A CAUSE OF SUBDURAL-HEMATOMA
    BUCCI, MN
    FARHAT, SM
    [J]. JOURNAL OF UROLOGY, 1986, 135 (04) : 803 - 804
  • [9] Caputi F, 1999, REV NEUROL, V155, P383
  • [10] CASTALDO JE, 1983, CANCER, V52, P1739, DOI 10.1002/1097-0142(19831101)52:9<1739::AID-CNCR2820520931>3.0.CO